INDEMNIFICATION AGREEMENTIndemnification Agreement • December 28th, 2022 • YishengBio Co., LTD • Pharmaceutical preparations
WHEREAS, the Company wishes for the Indemnitee to serve on its Board of Directors (the “Board”) or as an officer of the Company and wishes to provide the Indemnitee with specific contractual assurance of the Indemnitee’s rights to indemnification against litigation risks and expenses arising from his position as a Director or Officer (as defined below) to the full extent permitted by applicable law;
BUSINESS COMBINATION AGREEMENT by and among YishengBio Co., Ltd., Oceanview Bioscience Acquisition Co., Ltd., Hudson Biomedical Group Co., Ltd., and Summit Healthcare Acquisition Corp. dated as of September 29, 2022Business Combination Agreement • September 29th, 2022 • YishengBio Co., LTD • Blank checks • New York
This Business Combination Agreement, dated as of September 29, 2022 (this “Agreement”), is made and entered into by and among (i) YishengBio Co., Ltd., an exempted company limited by shares incorporated under the laws of the Cayman Islands (the “Company”), (ii) Oceanview Bioscience Acquisition Co., Ltd., an exempted company limited by shares incorporated under the laws of the Cayman Islands and a direct wholly owned subsidiary of the Company (“Merger Sub I”), (iii) Hudson Biomedical Group Co., Ltd., an exempted company limited by shares incorporated under the laws of the Cayman Islands and a direct wholly owned subsidiary of the Company (“Merger Sub II”, collectively with Merger Sub I, the “Merger Subs” and each, a “Merger Sub”), and (iv) Summit Healthcare Acquisition Corp., an exempted company limited by shares incorporated under the laws of the Cayman Islands (“SPAC”).
PLAN OF MERGERPlan of Merger • April 12th, 2023 • YS Biopharma Co., Ltd. • Pharmaceutical preparations
IN ACCORDANCE WITH ITEM 601(B)(10)(IV) OF REGULATION S-K, CERTAIN IDENTIFIED INFORMATION HAS BEEN OMITTED FROM THE EXHIBIT BECAUSE IT IS BOTH (1) NOT MATERIAL AND (2) THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. [***] INDICATES THAT...Concert Agreement • December 28th, 2022 • YishengBio Co., LTD • Pharmaceutical preparations
EMPLOYMENT AGREEMENTEmployment Agreement • August 15th, 2024 • LakeShore Biopharma Co., Ltd. • Pharmaceutical preparations • New York
This EMPLOYMENT AGREEMENT (the “Agreement”) is entered into as of [DATE] by and between LakeShore Biopharma Co., Ltd. (the “Company”), an exempted company duly incorporated and validly existing under the law of the Cayman Islands, and [NAME], an individual (the “Executive”). The term “Company” as used herein with respect to all obligations of the Executive hereunder shall be deemed to include the Company and all of its direct or indirect parent companies, subsidiaries, affiliates, or subsidiaries or affiliates of its parent companies (collectively, the “Group”).
ACTING-IN-CONCERT AGREEMENTIn-Concert Agreement • December 7th, 2022 • YishengBio Co., LTD • Pharmaceutical preparations
SHARE PURCHASE AGREEMENTShare Purchase Agreement • August 15th, 2024 • LakeShore Biopharma Co., Ltd. • Pharmaceutical preparations • New York
This Share Purchase Agreement (this “Agreement”) is made as of February 7, 2024 by and between YS Biopharma Co., Ltd., an exempted company incorporated in the Cayman Islands (the “Company”) and the purchaser identified on the signature pages hereto (the “Purchaser”). The Company, on one hand, and the Purchaser, on the other hand, are sometimes each referred to herein as a “Party” and collectively as the “Parties.”
